Mesenchymal Stem Cells for Treating Ocular Surface Diseases

Degenerative retinal diseases (RDD) are one of the leading causes of progressive vision loss and even blindness. Traditional treatments often fail to provide the desired effect, leaving patients with limited options. However, modern scientific advances have opened new horizons in vision restoration – mesenchymal stem cell (MSC) therapy. This approach has proven its effectiveness in combating degenerative processes in the retina, improving patients' conditions even in the later stages of diseases.

What Are Mesenchymal Stem Cells?

Mesenchymal stem cells (MSCs) are multifunctional cells capable of self-renewal and differentiation into various tissue types. Their key feature is their powerful regenerative properties, which promote the restoration of damaged retinal and corneal tissues. They also possess immunomodulatory capabilities, helping to reduce inflammatory processes that often accompany degenerative eye conditions.

How Do MSCs Help Treat Ocular Surface Diseases?

MSCs are used to regenerate retinal cellular structures and stimulate restorative processes in the eye. Their primary mechanisms of action include:

Secretion of neurotrophic factors, which support the viability of retinal cells;
Immunomodulatory effects, reducing inflammation and preventing further degeneration;
Improvement of microcirculation in the eye, which enhances tissue nourishment;
Stimulation of regenerative processes, aiding in the restoration of damaged cells.

Which Diseases Can Be Treated with MSCs?

MSC therapy is effective for the following conditions:

Retinal degeneration (including age-related macular degeneration and pigmentary retinitis);
Dry eye syndrome resistant to standard therapy;
Complications following corneal burns;
Corneal dystrophies and injuries after trauma or surgical interventions;
Autoimmune diseases affecting the ocular surface.

Scientific Research and Clinical Trials

Several preclinical and clinical studies have demonstrated that mesenchymal stem cells can effectively slow down degenerative processes in the retina and promote visual function recovery. Research published in Frontiers in Neuroscience and Nature confirms that MSC transplantation is safe and has high potential in treating patients with severe eye diseases.

Why Choose Us for Treatment?

Medical Expert collaborates only with verified, licensed clinics and experienced doctors specializing in stem cell therapy for retinal degenerative diseases. We:

Select clinics with the most advanced treatment methods;
Work with doctors who have years of experience in regenerative medicine;
Guarantee a personalized approach for each patient;
Assist with all organizational matters – from documentation to on-site support.

How Does the Treatment Process Work?

Consultation and patient evaluation – our specialists help select the optimal therapy program.
Collection and preparation of stem cells – using either autologous (own) or donor cells.
Cell administration – performed via injection or specialized transplantation techniques.
Rehabilitation period – doctors monitor the recovery process and provide recommendations to maintain the treatment effect.

Results and Effectiveness

Clinical data indicate that MSC therapy significantly improves vision quality, slows disease progression, and reduces symptoms in most patients. Although each case is unique, many patients experience significant improvement, opening new opportunities for an active life.

Schedule a Consultation Today!

If you or your loved ones suffer from degenerative eye diseases, don't miss the chance to improve your vision. Contact us to receive a detailed consultation on mesenchymal stem cell therapy and find the best solution for your case!